TY - JOUR
T1 - Red Cell Distribution Width as a Biomarker for Heart Failure
T2 - Still Not Ready for Prime-Time
AU - Nadar, Sunil K.
AU - Shaikh, Mohammad Mujtaba
N1 - Publisher Copyright:
© RADCLIFFE CARDIOLOGY 2019
PY - 2019
Y1 - 2019
N2 - We would like to thank García-Escobar and Ingelmo for their letter regarding our article on the use of biomarkers in routine clinical care for heart failure.1,2 It was with interest that we read their comments on the use of red cell volume distribution width (RDW) as another biomarker for use in the management of patients with heart failure. As mentioned in their letter, RDW is a measure of heterogeneity of red blood cell (RBC) volume or anisocytosis and not a measure of RBC size or volume itself.3 RDW is a number generated by automated blood count machines. Increased variations in RBC volume – that is, a high RDW, is seen in anaemic states (such as iron deficiency anaemia, sickle cell anaemia, thalassaemia and megaloblastic anaemia), in patients using chemotherapeutic agents, in cardiovascular disease, thyroid disease and myelodysplastic syndromes.3
AB - We would like to thank García-Escobar and Ingelmo for their letter regarding our article on the use of biomarkers in routine clinical care for heart failure.1,2 It was with interest that we read their comments on the use of red cell volume distribution width (RDW) as another biomarker for use in the management of patients with heart failure. As mentioned in their letter, RDW is a measure of heterogeneity of red blood cell (RBC) volume or anisocytosis and not a measure of RBC size or volume itself.3 RDW is a number generated by automated blood count machines. Increased variations in RBC volume – that is, a high RDW, is seen in anaemic states (such as iron deficiency anaemia, sickle cell anaemia, thalassaemia and megaloblastic anaemia), in patients using chemotherapeutic agents, in cardiovascular disease, thyroid disease and myelodysplastic syndromes.3
UR - http://www.scopus.com/inward/record.url?scp=85149270613&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85149270613&partnerID=8YFLogxK
U2 - 10.15420/cfr.2019.16.1
DO - 10.15420/cfr.2019.16.1
M3 - Article
AN - SCOPUS:85149270613
SN - 2057-7540
VL - 5
SP - 180
EP - 181
JO - Cardiac Failure Review
JF - Cardiac Failure Review
IS - 3
ER -
